Development and validation of a quantitative assay for the analysis of tamoxifen with its four main metabolites and the flavonoids daidzein, genistein and glycitein in human serum using liquid chromatography coupled with tandem mass spectrometry
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-08-15
著者
-
Schellens J
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Rosing H
Netherlands Cancer Inst. Amsterdam Nld
-
Rosing H.
Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
Rosing H.
Dept. Of Pharmacy And Pharmacology Slotervaart Hospital/netherlands Cancer Institute
-
Rosing H.
Department Of Pharmacy Slotervaart Hospital
-
Beijnen J.
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Beijnen J.
Department Of Medical Oncology The Netherlands Cancer Institute/antoni Van Leeuwenhoek Huis
-
Schellens J.
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Schellens J.
Department Of Medical Oncology Antoni Van Leeuwenhoek Hospital/the Netherlands Cancer Institute
-
Rosing H.
Department Of Pharmacy & Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
TEUNISSEN S.
Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute
-
SCHINKEL A.
Department of Molecular Biology, The Netherlands Cancer Institute
-
KOORNSTRA R.
Departments of Molecular Biology and Medical Oncology, Antoni van Leeuwenhoek Hospital/The Netherlan
-
LINN S.
Departments of Molecular Biology and Medical Oncology, Antoni van Leeuwenhoek Hospital/The Netherlan
-
Linn S.
Departments Of Molecular Biology And Medical Oncology Antoni Van Leeuwenhoek Hospital/the Netherland
-
Schinkel A.
Department Of Molecular Biology The Netherlands Cancer Institute
-
Teunissen S.
Department Of Pharmacy & Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
Koornstra R.
Departments Of Molecular Biology And Medical Oncology Antoni Van Leeuwenhoek Hospital/the Netherland
関連論文
- Quantitative and selective assay of 5-methylindirubine, an inhibitor of cyclin-dependent kinases, in murine plasma using coupled liquid chromatography and electrospray tandem mass spectrometry
- Bio-analysis of docetaxel and hydroxylated metabolites in human plasma by high-performance liquid chromatography and automated solid-phase extraction
- High-performance liquid chromatographic procedures for the quantitative determination of paclitaxel (Taxol) in human urine
- Development and validation of a quantitative assay for the measurement of two HIV-fusion inhibitors, enfuvirtide and tifuvirtide, and one metabolite of enfuvirtide (M-20) in human plasma by liquid chromatography-tandem mass spectrometry
- Enzymatic digestion as a tool for the LC-MS/MS quantification of large peptides in biological matrices : Measurement of chymotryptic fragments from the HIV-1 fusion inhibitor enfuvirtide and its metabolite M-20 in human plasma
- High-performance liquid chromatographic analysis for the determination of a novel polymer-bound camptothecin derivative (MAG-camptothecin) and free camptothecin in human plasma
- Liquid chromatography-tandem mass spectrometric assays for salinomycin in mouse plasma, liver brain and small intestinal contents and in OptiMEM cell culture medium
- Liquid chromatography-tandem mass spectrometric assay for the analysis of uracil, 5,6-dihydrouracil and β-ureidopropionic acid in urine for the measurement of the activities of the pyrimidine catabolic enzymes
- Liquid chromatographic assay for the antiviral nucleotide analogue tenofovir in plasma using derivatization with chloroacetaldehyde
- Bioanalysis and preliminary pharmacokinetics of the acridonecarboxamide derivative GF120918 in plasma of mice and humans by ion-pairing reversed-phase high-performance liquid chromatography with fluorescence detection
- Analysis of Ecteinascidin 743, a new potent marine-derived anticancer drug, in human plasma by high-performance liquid chromatography in combination with solid-phase extraction
- Quantification of topotecan and its metabolite N-desmethyltopotecan in human plasma, urine and faeces by high-performance liquid chromatographic methods
- Quantification of paclitaxel metabolites in human plasma by high-performance liquid chromatography
- Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection
- Review on the analysis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and its phase I and phase II metabolites in biological matrices, foodstuff and beverages
- Liquid chromatography-tandem mass spectrometric assay for pravastatin and two isomeric metabolites in mouse plasma and tissue homogenates
- Validation of a quantitative assay for human neutrophil peptide-1, -2, and -3 in human plasma and serum by liquid chromatography coupled to tandem mass spectrometry
- High-performance liquid chromatographic determination of the novel antitumour drug topotecan and topotecan as the total of the lactone plus carboxylate forms, in human plasma
- Development and validation of a liquid chromatography-tandem mass spectrometry assay for the analysis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and its metabolite 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-OH-PhIP) in plasma
- Liquid chromatography-tandem mass spectrometric assay for clobetasol propionate in human serum from patients with atopic dermatitis
- Quantitative assay for six potential breast cancer biomarker peptides in human serum by liquid chromatography coupled to tandem mass spectrometry
- Liquid chromatography-tandem mass spectrometric assay for the light sensitive tyrosine kinase inhibitor axitinib in human plasma
- A validated assay for the quantitative analysis of vatalanib in human EDTA plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry
- Development and validation of a quantitative assay for the analysis of tamoxifen with its four main metabolites and the flavonoids daidzein, genistein and glycitein in human serum using liquid chromatography coupled with tandem mass spectrometry
- Liquid chromatography-tandem mass spectrometric assay for sorafenib and sorafenib-glucuronide in mouse plasma and liver homogenate and identification of the glucuronide metabolite
- Liquid chromatography-tandem mass spectrometric assay for diclofenac and three primary metabolites in mouse plasma
- Quantitative bioanalysis of peptides by liquid chromatography coupled to (tandem) mass spectrometry
- A sensitive assay for the quantitative analysis of vinorelbine in mouse and human EDTA plasma by high-performance liquid chromatography coupled with electrospray tandem mass spectrometry
- High-performance liquid chromatographic determination of the antifungal drug fluconazole in plasma and saliva of human immunodeficiency virus-infected patients
- Quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in peripheral blood mononuclear cell lysate using liquid chromatograph coupled with tandem mass spectrometry
- Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography-triple quadrupole mass spectrometry
- Simultaneous quantification of the new HIV protease inhibitors atazanavir and tipranavir in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry
- A sensitive LC-MS/MS method for the quantitative analysis of the Echinacea purpurea constituent undeca-2-ene-8,10-diynoic acid isobutylamide in human plasma
- Analytical procedure for the determination of the new antitumour drug N-benzoylstaurosporine and three potential metabolites in human plasma by reversed-phase high-performance liquid chromatography